◆ TICKERBASEOpen interactive view →
◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Home › All stocks › S › STRO

Sutro Biopharma, Inc. (STRO) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Biotechnology · DATA UPDATED 2026-11-02

Sutro Biopharma, Inc. (STRO) operates in the Biotechnology industry and is headquartered in South San Francisco, United States with about 128 employees. Its market capitalization is roughly $151 million. In the fiscal year ended 2025-12-31, STRO reported $102M in revenue and ($191M) in net income.

Sutro Biopharma, Inc. operates as an oncology company. The company develops site-specific and novel-format antibody drug conjugates (ADCs) that enables its proprietary integrated cell-free protein synthesis platform, XpressCF; and site-specific conjugation platform, XpressCF+.

Interactive charts & full statements → Open the STRO valuation workbench →

STRO Revenue & Earnings History — Annual Income Statement

Income statementTTM → 2026-06-302025-12-312024-12-312023-12-312022-12-312021-12-31
Total Revenue$46M$102M$62M$154M$68M—
Operating Income (EBIT)($146M)($158M)($238M)($89M)($129M)—
Net Income($181M)($191M)($228M)($107M)($119M)—

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

STRO Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-31
Total Revenue$10M$14M$12M$10M$64M—
Operating Income (EBIT)($30M)($30M)($38M)($48M)($3M)—
Net Income($38M)($38M)($47M)($57M)($12M)—

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

STRO Free Cash Flow History

STRO Balance Sheet History

Balance sheet2025-12-312024-12-312023-12-312022-12-312021-12-31
Total Assets$174M$387M$471M$407M—
Total Liabilities$306M$343M$321M$190M—

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive STRO viewer.

Other Companies in Biotechnology

← STRNAll “S” companiesSTRR →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.